Reston ebolavirus spreads efficiently in pigs

December 21, 2020


Reston ebolavirus (RESTV) should be considered a livestock pathogen with potential to affect other mammals, including people, according to National Institutes of Health scientists. The caution comes from a study published in Proceedings of the National Academy of Sciences in which the scientists found that experimental piglets infected with RESTV developed severe respiratory disease and shed the virus from the upper respiratory tract. RESTV can infect humans but is not known to cause disease. Now the scientists express concern that pigs could serve as an "interim or amplifying host for ebolaviruses."

"The emergence of RESTV in pigs is a wake-up call as transmission into humans through direct contact with pigs or the food chain is a possibility," they state in their study report. Scientists from NIH's National Institute of Allergy and Infectious Diseases (NIAID) conducted the work at Rocky Mountain Laboratories in Hamilton, Montana.

Scientists first identified RESTV in 1989 in research monkeys shipped from the Philippines to Reston, Virginia. The virus also gained attention in 2008 when an outbreak swept through pigs in the Philippines. That outbreak led to the first association of pig-to-human RESTV transmission, prompting the World Health Organization to issue a global alert in February 2009. RESTV sequences also have been identified in pigs in China, and the scientists suggest officials monitor pigs for disease throughout the Philippines and Southeast Asia.

The NIAID scientists conducted their study to answer two key questions: could they cause disease in young pigs--mimicking natural infection with RESTV isolated from the 2008 swine outbreak--and if so, would those pigs shed virus through their respiratory tract? Their work confirmed that in fact the pigs developed severe pneumonia with virus shedding from the upper respiratory tract. They also determined that the age of the piglets at the time of infection--they used animals between three and seven weeks old--did not change the course of disease. Their work involved Yorkshire cross-bred pigs, which frequently are used in commercial pig production systems. RESTV has not been found in commercial pigs in the United States.

Continued studies in this project will examine whether co-infection with other swine viruses affects the ability of RESTV to cause severe disease in pigs and whether pigs have a broad role in hosting ebolaviruses.

E Haddock et al. Reston virus causes severe respiratory disease in young domestic pigs. PNAS
DOI: 10.1073/pnas.2015657118 (2020).


Heinz Feldmann, M.D., Ph.D., chief of NIAID's Laboratory of Virology, and Elaine Haddock, Ph.D., Laboratory of Virology, are available to comment.


To schedule interviews, please contact
Ken Pekoc,
(301) 402-1663,

NIAID conducts and supports research--at NIH, throughout the United States, and worldwide--to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.

About the National Institutes of Health (NIH):

NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit

NIH...Turning Discovery Into Health®

NIH/National Institute of Allergy and Infectious Diseases

Related Virus Articles from Brightsurf:

Researchers develop virus live stream to study virus infection
Researchers from the Hubrecht Institute and Utrecht University developed an advanced technique that makes it possible to monitor a virus infection live.

Will the COVID-19 virus become endemic?
A new article in the journal Science by Columbia Mailman School researchers Jeffrey Shaman and Marta Galanti explores the potential for the COVID-19 virus to become endemic, a regular feature producing recurring outbreaks in humans.

Smart virus
HSE University researchers have found microRNA molecules that are potentially capable of repressing the replication of human coronaviruses, including SARS-CoV-2.

COVID-19 - The virus and the vasculature
In severe cases of COVID-19, the infection can lead to obstruction of the blood vessels in the lung, heart and kidneys.

Lab-made virus mimics COVID-19 virus
Researchers at Washington University School of Medicine in St. Louis have created a virus in the lab that infects cells and interacts with antibodies just like the COVID-19 virus, but lacks the ability to cause severe disease.

Virus prevalence associated with habitat
Levels of virus infection in lobsters seem to be related to habitat and other species, new studies of Caribbean marine protected areas have shown.

Herpes virus decoded
The genome of the herpes simplex virus 1 was decoded using new methods.

A new biosensor for the COVID-19 virus
A team of researchers from Empa, ETH Zurich and Zurich University Hospital has succeeded in developing a novel sensor for detecting the new coronavirus.

How at risk are you of getting a virus on an airplane?
New 'CALM' model on passenger movement developed using Frontera supercomputer.

Virus multiplication in 3D
Vaccinia viruses serve as a vaccine against human smallpox and as the basis of new cancer therapies.

Read More: Virus News and Virus Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to